Follow-up of four HIV-infected individuals after administration of hepatitis c virus and GBV-C/hepatitis g virus contaminated intravenous immunoglobulin: Evidence for HCV but not for GBV-C/HGV transmission

Journal of Medical Virology

Volumn 53, Issue 1, 1997, Pages 25-30

  Berger, Annemarie ^a   Doerr, Hans Wilhelm ^a   Scharrer, Inge ^a   Weber, Bernard ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Laboratoires Reunis Kutter L   (Germany)

Author keywords

Acute HCV infection; Anti E2 antibody; GBV C HGV; HIV; Intravenous immunoglobulin; PCR

Indexed keywords

IMMUNOGLOBULIN G; VIRUS RNA;

ARTICLE; CASE REPORT; CONTAMINATION; FEMALE; GENE AMPLIFICATION; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HEPATITIS VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS DETECTION; VIRUS GENE; VIRUS TRANSMISSION;

ADULT; AGAMMAGLOBULINEMIA; BASE SEQUENCE; DNA PRIMERS; DRUG CONTAMINATION; FEMALE; FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; POLYMERASE CHAIN REACTION; RNA, VIRAL; THROMBOCYTOPENIA;

GB VIRUS C/HEPATITIS G VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0030773391     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199709)53:1<25::AID-JMV5>3.0.CO;2-S     Document Type: Article

References (13)

1. Berger A, Doerr HW, Preiser W, Weber B (1996): Lack of correlation between different hepatitis C virus screening and confirmatory assys. Journal of Virological Methods 59:141-146.
2. Giuberti T, Marin MG, Ferrari C, Marchelli S, Schianchi C, Degli-Antoni AM, Pizzocolo G, Fiaccadori F (1994): Hepatitis C virus viremia following clinical resolution of acute hepatitis C. Journal of Hepatology 20:666-671.
3. Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P (1996): Infection with hepatitis G virus among recipients of plasma products. Lancet 348:1352-1355.
4. Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih J W-K, Young L, Piatak M, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP (1996): Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 271:505-509.
5. Kurosaki M, Enomoto N, Marumo F, Sato C (1993): Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 18:1293-1299.
6. Naito M, Hayashi N, Hagiwara H, Katayama K, Kasahara A, Fusamoto H, Kato M, Masuzawa M, Kamada T (1994): Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C. Journal of Hepatology 20:755-759.
7. Nübling CM, Willkommen H, Löwer J (1995): Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 345: 1174.
8. Simons JN, Leary TP, Dawson GJ, Pilot-Matias T, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK (1995): Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1:564-569.
9. Rabenau H (1995): Virussicherheit von Blutprodukten: Aspekte der behördlichen Anforderungen. Laboratoriumsmedizin 19:523-533.
10. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, Engel AM (1997): Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 349:318-320.
11. Vento S, Cainelli F, Mirandola F, Cosco L, Di Perri G, Solbiati M, Ferraro T, Concia E (1996): Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 347:92-93.
12. Yap PL, McOmish F, Webster AD, Hammarstrom L, Smith CIE, Bjorkander J, Ochs HD, Fischer SH, Quinti I, Simmonds P (1994): Hepatitis C virus transmission by intravenous immunoglobulin. Journal of Hepatology 21:455-460.
13. Yu MW, Mason BL, Guo ZP, Tankersley DL, Nedjar S, Mitchell FD, Biswas RM (1995): Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 345:1173-1174.